We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca’s COVID-19 Vaccine Delivers Strong Immune Response, Study Confirms
AstraZeneca’s COVID-19 Vaccine Delivers Strong Immune Response, Study Confirms
AstraZeneca’s COVID-19 vaccine candidate, AZD1222, currently being evaluated in phase 3 global trials, delivers a strong immune response, according to a new UK study.